UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 903

Sortiert nach

0.2-[Formula Omitted] AlGaN/GaN High Electron-Mobility Transistors With Atomic Layer Deposition [Formula Omitted] Passivation

IEEE electron device letters, 2013-06, Vol.34 (6), p.744

2013

Volltextzugriff (PDF)

0.2- mu m AlGaN/GaN High Electron-Mobility Transistors With Atomic Layer Deposition Al 2 O 3 Passivation

IEEE electron device letters, 2013-06, Vol.34 (6), p.744-746

2013

Volltextzugriff (PDF)

0.2- \mu AlGaN/GaN High Electron-Mobility Transistors With Atomic Layer Deposition Passivation

IEEE electron device letters, 2013-06, Vol.34 (6), p.744-746

2013

Volltextzugriff (PDF)

0.2-μm AlGaN/GaN High Electron-Mobility Transistors With Atomic Layer Deposition Al2O3 Passivation

IEEE electron device letters, 2013-06, Vol.34 (6), p.744-746

2013

Volltextzugriff (PDF)

074 Summary of indirect comparison to evaluate efficacy of baricitinib with targeted synthetic and biologic disease anti-rheumatic drugs in patients with rheumatoid arthritis

Rheumatology (Oxford, England), 2019-04, Vol.58 (Supplement_3)

2019

Volltextzugriff (PDF)

1 H and 13 C nuclear magnetic resonance studies of ethenyl‐substituted benzenoid aromatic compounds

Magnetic resonance in chemistry, 1991-01, Vol.29 (1), p.2-8

1991

Volltextzugriff (PDF)

1H and 13C nuclear magnetic resonance studies of ethenyl-substituted benzenoid aromatic compounds

Magnetic resonance in chemistry, 1991-01, Vol.29 (1), p.2-8

1991

Volltextzugriff (PDF)

A 24 HR GLOBAL CAMPAIGN TO ASSESS PRECISION TIMING OF THE MILLISECOND PULSAR J1713+0747

The Astrophysical journal, 2014-10, Vol.794 (1), p.21

2014

Volltextzugriff (PDF)

(2R)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

Journal of medicinal chemistry, 2005-01, Vol.48 (1), p.141-151

2005

Volltextzugriff (PDF)

(2R)-4-Oxo-4[3-(Trifluoromethyl)-5,6-diihydro:1,2,4}triazolo[4,3-a}pyrazin-7(8H)-y1]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

Journal of medicinal chemistry, 2010-11, Vol.48 (2005)

2010

Volltextzugriff (PDF)

4D‐Var Inversion of European NH3 Emissions Using CrIS NH3 Measurements and GEOS‐Chem Adjoint With Bi‐Directional and Uni‐Directional Flux Schemes

Journal of geophysical research. Atmospheres, 2022-05, Vol.127 (9), p.e2021JD035687-n/a

2022

Volltextzugriff (PDF)

5‑Halogenation of Uridine Suppresses Protonation-Induced Tautomerization and Enhances Glycosidic Bond Stability of Protonated Uridine: Investigations via IRMPD Action Spectroscopy, ER-CID Experiments, and Theoretical Calculations

Journal of the American Society for Mass Spectrometry, 2022-11, Vol.33 (11), p.2165-2180

2022

Volltextzugriff (PDF)

The 50-year Landsat collection 2 archive

Science of Remote Sensing, 2023-12, Vol.8, p.100103, Article 100103

2023

Volltextzugriff (PDF)

54. tGLI1 IS AN ACTIONABLE THERAPEUTIC TARGET IN BREAST CANCER BRAIN METASTASES

Neuro-oncology advances, 2020-08, Vol.2 (Supplement_2), p.ii11-ii11

2020

Volltextzugriff (PDF)

A 802.11 based slotted dual-channel reservation MAC protocol for in-building multi-hop networks

Mobile networks and applications, 2005-10, Vol.10, p.593-606

2005

Volltextzugriff (PDF)

A 802.11 Based Slotted Dual-Channel Reservation MAC Protocol for In-Building Multi-Hop Networks

Mobile networks and applications, 2005-10, Vol.10 (5), p.593-606

2005

Volltextzugriff (PDF)

802.11 mesh networks with two-radio access points

IEEE International Conference on Communications, 2005. ICC 2005. 2005, 2005, Vol.5, p.3609-3615 Vol. 5

2005

Volltextzugriff (PDF)

Abstract 14235: Hepatocyte Tissue Plasminogen Activator Limits Very-Low-Density Lipoprotein Production via Inhibiting ApoB-Microsomal Transfer Protein Interaction and ApoB Lipidation

Circulation (New York, N.Y.), 2022-11, Vol.146 (Suppl_1)

2022

Volltextzugriff (PDF)

Abstract 1979: JAK2/STAT3 and TrkA pathways are frequently co-activated in triple-negative and HER2-enriched breast cancers and the co-activation correlates with an increased potential of metastasis

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1979-1979

2021

Volltextzugriff (PDF)

Abstract 2433: Targeting tGLI1 pharmacologically as a new therapeutic strategy for breast cancer brain metastases

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.2433-2433

2022

Volltextzugriff (PDF)

Abstract 2866: Truncated glioma-associated oncogene homolog 1 (tGLI1) is an actionable therapeutic target in breast cancer brain metastases

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.2866-2866

2021

Volltextzugriff (PDF)

Abstract 3021: Integrated pharmacokinetic (PK)/pharmacodynamic (PD) modeling leveraging PK, biomarker, and safety data to support dose and schedule selection for the BET inhibitor BMS-986158

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.3021-3021

2020

Volltextzugriff (PDF)

Abstract 3389: An exosomal miRNA-based liquid biopsy signature for the noninvasive early detection of pancreatic ductal adenocarcinoma

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.3389-3389

2022

Volltextzugriff (PDF)

1 – 25 von 903

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(764)
Mit Volltextzugriff
(829)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(633)
Life Sciences & Biomedicine
(356)
Humans
(205)
Technology
(196)
Physical Sciences
(158)
Animals
(139)
Male
(108)
Chemistry
(99)
Female
(96)
Science & Technology - Other Topics
(84)
Mice
(82)
Physics
(79)
Engineering
(78)
Materials Science
(71)
Biological And Medical Sciences
(69)
Computer Science
(68)
Materials Science, Multidisciplinary
(59)
Pharmacology & Pharmacy
(56)
Engineering, Electrical & Electronic
(52)
Proteins
(52)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

0.2-[Formula Omitted] AlGaN/GaN High Electron-Mobility Transistors With Atomic Layer Deposition [Formula Omitted] Passivation

0.2- mu m AlGaN/GaN High Electron-Mobility Transistors With Atomic Layer Deposition Al 2 O 3 Passivation

0.2- \mu AlGaN/GaN High Electron-Mobility Transistors With Atomic Layer Deposition Passivation

0.2-μm AlGaN/GaN High Electron-Mobility Transistors With Atomic Layer Deposition Al2O3 Passivation

074 Summary of indirect comparison to evaluate efficacy of baricitinib with targeted synthetic and biologic disease anti-rheumatic drugs in patients with rheumatoid arthritis

1 H and 13 C nuclear magnetic resonance studies of ethenyl‐substituted benzenoid aromatic compounds

1H and 13C nuclear magnetic resonance studies of ethenyl-substituted benzenoid aromatic compounds

A 24 HR GLOBAL CAMPAIGN TO ASSESS PRECISION TIMING OF THE MILLISECOND PULSAR J1713+0747

(2R)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

(2R)-4-Oxo-4[3-(Trifluoromethyl)-5,6-diihydro:1,2,4}triazolo[4,3-a}pyrazin-7(8H)-y1]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

(2S,3S)-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-(4-[1,2,4]triazolo[1,5-a]- pyridin-6-ylphenyl)butanamide: A Selective α-Amino Amide Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

4D‐Var Inversion of European NH 3 Emissions Using CrIS NH 3 Measurements and GEOS‐Chem Adjoint With Bi‐Directional and Uni‐Directional Flux Schemes

4D‐Var Inversion of European NH3 Emissions Using CrIS NH3 Measurements and GEOS‐Chem Adjoint With Bi‐Directional and Uni‐Directional Flux Schemes

5‑Halogenation of Uridine Suppresses Protonation-Induced Tautomerization and Enhances Glycosidic Bond Stability of Protonated Uridine: Investigations via IRMPD Action Spectroscopy, ER-CID Experiments, and Theoretical Calculations

The 50-year Landsat collection 2 archive

54. tGLI1 IS AN ACTIONABLE THERAPEUTIC TARGET IN BREAST CANCER BRAIN METASTASES

A 802.11 based slotted dual-channel reservation MAC protocol for in-building multi-hop networks

A 802.11 Based Slotted Dual-Channel Reservation MAC Protocol for In-Building Multi-Hop Networks

802.11 mesh networks with two-radio access points

Abstract 14235: Hepatocyte Tissue Plasminogen Activator Limits Very-Low-Density Lipoprotein Production via Inhibiting ApoB-Microsomal Transfer Protein Interaction and ApoB Lipidation

Abstract 1979: JAK2/STAT3 and TrkA pathways are frequently co-activated in triple-negative and HER2-enriched breast cancers and the co-activation correlates with an increased potential of metastasis

Abstract 2433: Targeting tGLI1 pharmacologically as a new therapeutic strategy for breast cancer brain metastases

Abstract 2866: Truncated glioma-associated oncogene homolog 1 (tGLI1) is an actionable therapeutic target in breast cancer brain metastases

Abstract 3021: Integrated pharmacokinetic (PK)/pharmacodynamic (PD) modeling leveraging PK, biomarker, and safety data to support dose and schedule selection for the BET inhibitor BMS-986158

Abstract 3389: An exosomal miRNA-based liquid biopsy signature for the noninvasive early detection of pancreatic ductal adenocarcinoma

Suchergebnisse filtern